An oral formula of vanillin and wheat germ oil for treatment of mild and moderate covid-19 viral disease: a randomized controlled trial

HIGHLIGHTS

• What: The role of CDK6 and CDK6 inhibitors is well acknowledged by the review reported by Ochsner et_al . This study aims to perform a clinical trial for an oral herbal mix with a profile that encompasses activity as inhibitors for the inflammatory process.
• Who: phar pharmaceutics from the Clinical Pharmacist at Alexandria Main University Hospital, Clinical Pharmacy and Pharmacy have published the article: Hanya Hesham Sweilam, et al. JAPS, 2(1), 2025 1 ISSN: 3009-7061 DOI: 10.21608/japs.2024.286753.1026, in the Journal: (JOURNAL) of 24/Oct/2022
• How: The . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.